p14ARF repression induced by promoter methylation associated with metastasis in esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 27, Issue 2, 2014, Pages 182-187

  Ling, Y ^a   Zhang, C ^a,b   Shen, R ^c   Xu, Y ^b   Zhu, C ^a   Lu, M ^a   Liu, Y ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Department of Oncology   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

5 Aza CdR; Esophagus carcinoma; Methylation; p14ARF

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA;

ADULT; ARTICLE; CANCER CELL; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5-AZA-CDR; ESOPHAGUS CARCINOMA; METHYLATION; P14ARF;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 84893003134     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01413.x     Document Type: Article

References (20)

1. Jemal A, Murray T, Samuels A etal. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
2. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24: 729-735.
3. Lin D C, Du X L, Wang M R. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus 2009; 22: 9-20.
4. Sherr C J. Cancer cell cycles. Science 1996; 274: 1672-1677.
5. Carnero A, Hannon G J. The INK4 family of CDK inhibitors. Curr Top Microbiol Immunol 1998; 227: 43-55.
6. Pomerantz J, Schreiber-Agus N, Liegeois N J etal. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92: 713-723.
7. Xing E P, Nie Y, Song Y etal. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999; 5: 2704-2713.
8. Lam K Y, Law S, Tung P H etal. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch Pathol Lab Med 2000; 124: 228-233.
9. Deaton A M, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011; 25: 1010-1022.
10. Robertson K D, Jones P A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 1998; 18: 6457-6473.
11. Sarbia M, Geddert H, Klump B etal. Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract. Int J Cancer 2004; 111: 224-228.
12. Chuang J C, Yoo C B, Kwan J M etal. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. Mol Cancer Ther 2005; 4: 1515-1520.
13. Ling Y, Huang G, Fan L etal. CpG island methylator phenotype of cell-cycle regulators associated with TNM stage and poor prognosis in patients with oesophageal squamous cell carcinoma. J Clin Pathol 2011; 64: 246-251.
14. Esteller M, Tortola S, Toyota M etal. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000; 60: 129-133.
15. Wang S, Zhu J. Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. J Biol Chem 2003; 278: 18842-18850.
16. Ishii T, Murakami J, Notohara K etal. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut 2007; 56: 13-19.
17. Cheng T H, Hsu P K, Li A F etal. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2009; 135: 1577-1582.
18. Jones P A, Baylin S B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
19. Kuwano H, Kato H, Miyazaki T etal. Genetic alterations in esophageal cancer. Surg Today 2005; 35: 7-18.
20. Bender C M, Pao M M, Jones P A. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95-101.